News
Milano Finanza Class CNBC interview | Fine Foods & Pharmaceuticals: focus on buyback plan, Pharmatek acquisition and Star translisting
Our CEO Giorgio Ferraris was a guest in the analysis dedicated to the AIM Italia market of Milano Finanza Class CNBC, talking about the recent acquisition of Pharmatek-PMC and the next translisting plan towards the Star segment of the MTA market of Borsa Italiana.
